Zobrazeno 101 - 110
of 532
pro vyhledávání: ''
Autor:
Hiroaki Iwamoto, Yoshifumi Kadono, Kouji Izumi, Kazuyoshi Shigehara, Atsushi Mizokami, Suguru Kadomoto, Tomoyuki Makino, Hiroshi Yaegashi, Renato Naito
Publikováno v:
Anticancer Research. 40:1141-1146
Background/aim This study aimed to assess the efficacy and toxicity of second-line chemotherapy, especially combination chemotherapy, for advanced or metastatic urothelial cancer. Patients and methods This retrospective analysis included patients who
Publikováno v:
Anticancer Research. 40:1175-1181
Background/aim This study aimed to evaluate the association of sarcopenia and Clinical Outcomes with esophageal cancer under neoadjuvant chemoradiotherapy (CRT). Patients and methods A retrospective study assessing patients with esophageal cancer who
Autor:
Tatsunori Miyata, Kensuke Yamamura, Takanobu Yamao, Hidetoshi Nitta, Daisuke Kuroda, Yuki Kitano, Kota Arima, Hideo Baba, Tsugio Eto, Yo-ichi Yamashita, Hirohisa Okabe, Daisuke Hashimoto
Publikováno v:
Anticancer Research. 40:1023-1027
Background/aim Preoperative evaluation of resectability of pancreatic cancer (PC) is difficult, so that staging laparoscopy (SL) has come to be used for detecting occult metastases. We aimed to evaluate the prognostic impact of SL in comparison with
Autor:
Gerd Jomrich, Ruth Baumgartner, Hossein Taghizadeh, Matthias Preusser, Aysegül Ilhan-Mutlu, Sebastian F. Schoppmann
Publikováno v:
Anticancer Research. 40:965-975
BACKGROUND/AIM A standard treatment recommendation for advanced stage gastroesophageal cancer is still missing. PATIENTS AND METHODS We retrospectively analyzed clinical data of patients with inoperable locally advanced or metastatic gastroesophageal
Autor:
Simonetta Bianchi, Irene Renda, Milo Giani, Tommaso Susini, Ketty Tavella, A. Villanucci, Ermanno Vanzi, Arianna Vallario, Jacopo Nori
Publikováno v:
Anticancer Research. 40:1079-1085
Background/aim We evaluated the efficacy of neoadjuvant chemotherapy (NACT) in reducing locally-advanced breast cancer (LABC) size, thus improving breast-conserving surgery (BCS) rates, as well as its long-term outcome. Patients and methods We analyz
Publikováno v:
Anticancer Research. 40:991-997
Aim To evaluate the efficacy of chemotherapy with itraconazole for advanced or recurrent gastric cancer. Patients and methods Patients with human epidermal growth factor receptor 2 (HER2) negative unresectable gastric cancer referred to our hospital
Autor:
Itaru Hashimoto, Yukio Maezawa, Yasushi Rino, Masaaki Murakawa, Norio Yukawa, Yosuke Atsumi, Kazuki Kano, Ayako Tamagawa, Toru Aoyama, Masakatsu Numata, Hiroshi Tamagawa, Takashi Oshima, Munetaka Masuda, Kentaro Hara, Keisuke Kazama, Daisuke Machida, Keisuke Komori
Publikováno v:
Anticancer Research. 40:1087-1093
BACKGROUND The short- and long-term outcomes of esophagectomy for esophageal cancer were fully evaluated in patients older than 75 years of age. PATIENTS AND METHODS The present study selected patients who received esophagectomy for esophageal cancer
Autor:
Naotaka Sakamoto, Masaki Shiota, Masahiko Harano, Narihito Seki, Takakazu Yunoki, Shuji Hasegawa, Kentaro Kuroiwa, Motonobu Nakamura, Toshihisa Tomoda, Masatoshi Eto, Akira Yokomizo
Publikováno v:
Anticancer Research. 40:335-339
Background/aim The novel taxane cabazitaxel has been shown to exert excellent anticancer effects after androgen receptor axis-targeting (ARAT) agents in clinical data, but not in in vitro data. We investigated the clinical outcome of cabazitaxel chem
Autor:
Elena Guerini-Rocco, Valeria Stati, Davide Radice, Filippo de Marinis, Ester Del Signore, Antonio Passaro, Letizia Gianoncelli, Chiara Catania, Caterina Fumagalli, Massimo Barberis, Gianluca Spitaleri
Publikováno v:
Anticancer Research. 40:427-433
BACKGROUND/AIM The role of anti-PD1/PD-L1 therapy (IO) in NSCLC harboring driver mutations is questionable. This study aimed to examine the efficacy of IO in patients with non-small cell lung cancer (NSCLC) with a KRAS mutation (KRAS+). PATIENTS AND
Autor:
Takaki Yoshikawa, Takashi Oshima, Masaaki Murakawa, Norio Yukawa, Hiroshi Tamagawa, Keisuke Kazama, Yukio Maezawa, Yasushi Rino, Itaru Hashimoto, Munetaka Masuda, Keisuke Koumori, Kentaro Hara, Masakatsu Numata, Yosuke Atsumi, Kazuki Kano, Toru Aoyama, Takanobu Yamada
Publikováno v:
Anticancer Research. 40:405-412
BACKGROUND/AIM To evaluate the outcomes of curative resection for Borrmann type IV gastric cancer through an analysis of the clinical, surgical and pathological data and through identifying which of these prognostic factors are associated with surviv